Roche (PINK:RHHBY) tapped Vivonoetics and Great Lakes NeuroTechnologies, to provide a wearable respiratory testing device to Roche’s Firefish study. The company’s study aims to evaluate drug efficacy compared to respiratory muscle function and breathing patterns in infants treated for spinal muscular atrophy. Devices traditionally used to measure breathing include masks and mouthpieces, which aren’t always practical for monitoring infants. […]
Great Lakes NeuroTechnologies
Great Lakes NeuroTech said it won $1.9 million from the National Institute of Health to fund development and commercialization of a deep brain stimulation device for patients with Parkinsons disease. The device platform will combine wearable motor symptom sensing abilities and a DBS system into an integrated unit, as well as intelligent algorithms for searching […]
A Cleveland startup is looking for strategic partners for its web-based systems that assesses the severity of Parkinson’s disease symptoms and helps doctors better tailor medications to people with Parkinson’s.
Great Lakes NeuroTechnologies has been around since 2006 as a division of Cleveland Medical Devices, but was spun off earlier this year as a stand-alone company to focus on movement disorders.